Quantcast

Latest Menorrhagia Stories

dd8bc982e7f4c28b0a33392f437294c21
2010-03-24 08:08:13

Scientists described yesterday the discovery of a new drug, which is currently in Phase II clinical trials, designed to specifically target the root cause of painful menstrual cramps, not just the symptoms.

2009-11-16 15:11:00

BEDFORD, Mass., Nov. 16 /PRNewswire-FirstCall/ -- Hologic, Inc.

2009-11-13 14:17:00

SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

2009-10-06 05:58:00

SOUTHAMPTON, England, October 6 /PRNewswire/ -- Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials.

2009-10-01 16:58:00

WAYNE, N.J., Oct. 1 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc., announced today that the U.S.

2009-10-01 16:17:00

SILVER SPRING, Md., Oct. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention.